tbuckley/cabot-search huggingface dataset:
From Other Pages
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Should eponyms be abandoned?
Authors: Judith Whitworth, Alexander Woywodt
Journal: BMJ (2007)

Medicine has been enthusiastic in naming tests, symptoms, and diseases after their discoverers. <b>Alexander Woywodt</b> and <b>Eric Matteson</b> argue that eponyms are no longer appropriate, but <b>Judith A Whitworth</b> believes they remain a useful reflection of medical history
Small Cell Lung Cancer Clinical Practice Guidelines in Oncology
Journal: Journal of the National Comprehensive Cancer Network (2004)

Small cell lung cancer (SCLC) accounts for 15% to 25% of all lung cancers. About 98% of SCLC is attributed to cigarette smoking, whereas the remaining cases are presumably caused by environmental or genetic factors. In 2003, an estimated 34,000 new cases of SCLC will have been diagnosed in the United States. SCLC is distinguished from non-small cell lung cancer by its rapid doubling time, high growth fraction, and early development of widespread metastases.For the most recent version of the guidelines, please visit NCCN.org
Developmental Effects after Inhalation Exposure of Gravid Rabbits and Rats to Ethylene Glycol Monoethyl Ether
Authors: F. D. Andrew, B. D. Hardin
Journal: Environmental Health Perspectives (1984)

The effects of ethylene glycol monoethyl ether (EGEE) were determined on development in utero. Pregnant New Zealand White rabbits were exposed to air or 160 or 617 ppm EGEE for 7 hr/day from 1 to 18 days of gestation (dg). Virgin Wistar rats were exposed to 150 or 649 ppm EGEE or air 5 days/week for the 3 weeks immediately preceding their breeding. Sperm-positive rats were subsequently exposed to air or 202 or 767 ppm EGEE for 7 hr/day from 1 to 19 dg. Group sizes were 29 to 38 per concentration for both species. Pregestational exposure of rats had no effect on mating success, and there was no effect of EGEE exposure on establishment of pregnancy in either species. Rabbits exposed to the both concentrations had decreased food intake and depressed weight gain. Exposure-related mortality occurred in the 617 ppm EGEE group of rabbits. The only toxic sign seen in rats was reduced weight gain after exposure to 767 ppm EGEE. Exposure induced high embryomortality at maternal toxic concentrations in rats and rabbits, while lower levels induced fetal growth retardation in rats but not in rabbits. Gestational exposure increased the incidence of anomalies and variations; these were primarily of soft tissues in rabbits and of skeleton in rats. Thus, significant evidence of terata, fetal growth retardation and embryomortality were induced in rabbits and rats at levels that were below or similar to those that induced maternal manifestation of toxicity. These data implicate EGEE as a teratogen.
Clinical Psychopharmacology
Authors: Frank J. Ayd
Journal: JAMA (1978)

<b>Mind-Influencing Drugs: Effective Management of Patients With Emotional Illness,</b>edited by Martin Goldberg and Gerald Egelston, 389 pp, with illus, $19.50, Littleton, PSG (545 Great Rd, Littleton, MA 01460), 1978. These recent additions to the everexpanding list of books on psychopharmacology belong in the category of those suited primarily for nonpsychiatrist physicians. Each is the product of teaching seminars. Each is multiauthored and consists of chapters ranging in quality from mediocre to good. The contributors to Bernstein's book, among the leaders in American psychopharmacology, are frequent contributors to journals and books. What they say in their chapters, they have written many times elsewhere. Nevertheless, each chapter contains information and references to sources of information that can enhance knowledge of psychopharmacotherapy and improve prescribing skills. <i>Mind-Influencing Drugs</i>is a book written by clinicians for clinicians. It certainly covers the spectrum of emotional, behavioral, and psychic disorders physicians see in their daily
A once-per-week or every-two-week dosing regimen is more efficacious for the TIR7 agonist JNJ-64794964 (JNJ-4964) to induce an anti-hepatitis B virus (HBV) effect and HBV-specific immune responses in AAV-HBV mice
Authors: Florence Herschke, Chris Li, Ren Zhu, Quinglin Han, Qun Wu, Qing Lu, Tse-i Lin, An De Creus
Journal: Journal of Hepatology (2020)
A Preventive Intervention for Pregnant Women on Public Assistance at Risk for Postpartum Depression
Authors: Caron Zlotnick
Journal: American Journal of Psychiatry (2006)

Objective: Promising results were obtained in an earlier pilot study of a preventive intervention based on the principles of interpersonal psychotherapy to reduce the risk of postpartum major depressive disorder. In this study, the authors examined whether the intervention would reduce the risk of postpartum major depressive disorder in a larger sample of pregnant women. Method: Ninety-nine pregnant women on public assistance who were assessed to be at risk for postpartum depression were randomly assigned to receive standard antenatal care plus the intervention or standard antenatal care only. Diagnostic interviews were administered 3 months after delivery to assess for major depressive disorder. Results: Within 3 months after delivery, eight (20%) of the women in the standard antenatal care condition had developed postpartum major depressive disorder, compared with two (4%) in the intervention condition. Conclusions: This study provides further evidence for the efficacy of a brief intervention to reduce the occurrence of major depressive disorder among financially disadvantaged women during a postpartum period of 3 months.
Prostate Cancer: Emerging Concepts
Authors: William R. Fair
Journal: Annals of Internal Medicine (1996)

Letters15 December 1996Prostate Cancer: Emerging ConceptsWilliam R. Fair, MD and Marc B. Garnick, MDWilliam R. Fair, MDMemorial Sloan-Kettering Cancer Center, New York, NY 10021.Beth Israel Deaconess Medical Center, Boston, MA 02215.Search for more papers by this author and Marc B. Garnick, MDMemorial Sloan-Kettering Cancer Center, New York, NY 10021.Beth Israel Deaconess Medical Center, Boston, MA 02215.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-125-12-199612150-00034 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:Dr. Wilt has misinterpreted the content of our two-part article as endorsing early detection and screening for prostate cancer. Our purpose in writing this Update was to inform the nononcologist of the current state of important developments in prostate cancer. We specifically did not address the issues of screening for the early detection of prostate cancer and referred to the forthcoming report by the Clinical Evaluation Task Force of the American College of Physicians.Nonetheless, the comments by Dr. Wilt deserve rebuttal. Although we agree with the American Urological Association Panel that data on screening are inadequate to ... Author, Article, and Disclosure InformationAuthors: William R. Fair, MD; Marc B. Garnick, MDAffiliations: Memorial Sloan-Kettering Cancer Center, New York, NY 10021.Beth Israel Deaconess Medical Center, Boston, MA 02215. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 15 December 1996Volume 125, Issue 12Page: 1015KeywordsAntigensCancer screeningCancer treatmentComplete blood countDigital rectal examinationProstate cancer ePublished: 15 August 2000 Issue Published: 15 December 1996 Copyright & PermissionsCopyright © 1996 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Analysis of HLA-DRB1 alleles in Japanese patients with chronic myelogenous leukemia
Authors: M Yasukawa, H Ohminami, K Kojima, K Inokuchi, Y Nishimura, S Fujita
Journal: American Journal of Hematology (2000)

To clarify the association between HLA-DRB1 alleles and chronic myelogenous leukemia (CML), the HLA-DRB1 allele frequencies in 50 Japanese patients each with b2a2 and b3a2 CML and 127 healthy Japanese individuals were examined. In the patients with b2a2 CML, the frequencies of HLA-DRB1*0405, DRB1*08032, and DRB1*1502 were low and that of HLA-DRB1*1201 was high in comparison with the healthy individuals. The frequencies of HLA-DRB1*0403, DRB1*0802, DRB1*1403, and DRB1*1405 were high, and those of HLA-DRB1*08032 and DRB1*1501 were low in the patients with b3a2 CML. The present results suggest positive and negative associations between certain HLA-DRB1 alleles and CML.
Software
Authors: John C. Steiner
Journal: JAMA (1991)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Effects of two antihistamine drugs on actual driving performance
Authors: Erik Hagg, Mikael Eklund
Journal: BMJ (1984)

Case reports CASE 1The patient was a 19 year old previously healthy man who was injured while ski jumping and sustained complete tetraplegia.X ray examinations disdosed fractures of C4 and C5.On admission to hospital he had normal serum concentrations of calcium, phosphate, creatinine, and parathyroid and thyroid hormones.Repeated chest x ray films were normal, as were x ray films of the skull, lumbar spine, and pelvis.
Childhood Chloroquine Poisonings— Wisconsin and Washington
Journal: JAMA (1988)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Correction: Silencing of HSP90 Cochaperone AHA1 Expression Decreases Client Protein Activation and Increases Cellular Sensitivity to the HSP90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin
Authors: Joanna L. Holmes, Swee Y. Sharp, Steve Hobbs, Paul Workman
Journal: Cancer Research (2019)

In the original version of this article (1), some images were inadvertently duplicated in Fig. 2B, and in addition there was splicing of images in Fig. 2C (left panel) that was clear but not indicated by a vertical line. The findings and conclusions of the article remain the same. The errors have been corrected in the latest online PDF version of the article. The authors regret this error.
Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin’s Disease: Mature Results of a Prospective Clinical Trial
Authors: Sandra J. Horning, Richard T. Hoppe, Sheila Breslin, Nancy L. Bartlett, B. William Brown, Saul A. Rosenberg
Journal: Journal of Clinical Oncology (2002)

PURPOSE: To provide more mature data on the efficacy and complications of a brief, dose-intense chemotherapy regimen plus radiation therapy (RT) to bulky disease sites for locally extensive and advanced-stage Hodgkin’s disease. PATIENTS AND METHODS: One hundred forty-two patients with stage III or IV or locally extensive mediastinal stage I or II Hodgkin’s disease received Stanford V chemotherapy for 12 weeks followed by 36-Gy RT to initial sites of bulky (≥ 5 cm) or macroscopic splenic disease. Freedom from progression (FFP), overall survival (OS), and freedom from second relapse (FF2R) were determined using life-table estimates. Outcomes were analyzed according to the international prognostic score. Late effects of treatment were recorded in follow-up. RESULTS: With a median follow-up of 5.4 years, the 5-year FFP was 89% and the OS was 96%. No patient progressed during treatment, and there were no treatment-related deaths. FFP was significantly superior among patients with a prognostic score of 0 to 2 compared with those with a score of 3 and higher (94% v 75%, P &lt; .0001). No secondary leukemia was observed. To date, there have been 42 pregnancies after treatment. Among 16 patients who relapsed, the FF2R was 69% at 5 years. CONCLUSION: These data confirm our preliminary report that Stanford V chemotherapy with RT to bulky disease sites is highly effective in locally extensive and advanced Hodgkin’s disease. It is most important to compare this approach with standard doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy in the ongoing intergroup trial (E2496) to determine whether Stanford V with or without RT represents a therapeutic advance.
Is the critical reader dead?
Authors: A. Soffer
Journal: JAMA (1967)

The illustrations in a communication which recently appeared in a reputable medical journal looked vaguely familiar to me. A hurried search in our periodical files provided a full explanation for this episode of apparent déjà vu. A truncated version of the report and a few of the identical figures (obviously provided by the senior investigator) had been printed in a medical news magazine several months before. Staffs of journals representing every medical discipline are reporting comparable experiences. Thus, in many instances, the pattern of communication between investigator and clinician has altered dramatically. Intensive efforts to provide a plethora of news reports written exclusively for physicians is a recent phenomenon. Has introduction of mass distribution news periodicals for the physician decreased the importance of traditional medical journals? Are these media truly "competitive," or are the functions they serve so different that the discretionary reader would find it impossible to substitute one
FOURTH OF JULY INJURIES AND TETANUS.
Journal: JAMA (1906)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Delayed-Onset Heparin-Induced Thrombocytopenia
Journal: Annals of Internal Medicine (2002)

Summaries for Patients5 February 2002Delayed-Onset Heparin-Induced ThrombocytopeniaSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-136-3-200202050-00004 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?Heparin is a blood thinner that prevents or treats abnormal blood clots in the veins. It also causes several complications. One serious complication is an “autoimmune” reaction. In this complication, heparin molecules combine with a body protein called platelet factor 4. This leads to the production of antibodies that attack blood platelets, which are necessary for forming blood clots. The damaged platelets may trigger uncontrolled clot formation. This life-threatening situation, known as heparin-induced thrombocytopenia, occurs in 3% of heparin-treated patients. Although heparin-induced thrombocytopenia usually occurs within 5 to ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Delayed-Onset Heparin-Induced Thrombocytopenia.” It is in the 5 February 2002 issue of Annals of Internal Medicine (volume 136, pages 210-215). The authors are L Rice, WK Attisha, A Drexler, and JL Francis.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. Previousarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoDelayed-Onset Heparin-Induced Thrombocytopenia Lawrence Rice , Walid K. Attisha , Alane Drexler , and John L. Francis Metrics 5 February 2002Volume 136, Issue 3Page: I-34KeywordsAntibodiesArteriesBlood vesselsHeparinHeparin-induced thrombocytopeniaPatientsPlateletsProteinsThrombosisVeins ePublished: 5 February 2002 Issue Published: 5 February 2002 Copyright & PermissionsCopyright © 2002 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Protoplasma-Monographien
Journal: JAMA (1935)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A CASE OF TOTAL BLINDNESS; POSSIBLY DUE TO AN OVERDOSE OF QUININ.
Journal: JAMA (1996)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal